Skip to content
drillr.ai
Sign up

SLXN

Silexion Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · IL

$0.35
+0.06%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue—————
Cost of Revenue9.0K————
Gross Profit(9.0K)————
Operating Expenses
R&D Expense9.1M7.1M5.8M3.7M3.2M
SG&A Expense5.0M4.5M6.7M928.0K577.0K
General & Admin Expense3.5M4.5M6.7M928.0K577.0K
Selling & Marketing Expense—————
Other Expenses(23.3M)(23.3M)25.0K45.0K57.0K
Total Operating Expenses(9.1M)(11.6M)12.6M4.7M3.9M
Cost and Expenses(9.1M)(11.6M)12.6M4.7M3.9M
Operating Income (EBIT)9.1M11.6M(12.6M)(4.7M)(3.9M)
Non-Operating
Interest Income154.0K142.0K1.0K153.0K114.0K
Interest Expense6.0K13.0K52.0K9.0K85.0K
Net Interest Income148.0K129.0K(51.0K)144.0K29.0K
Other Non-Op Income/Expense(23.1M)(23.5M)(3.9M)(395.0K)396.0K
Non-Operating Income (excl Interest)23.2M23.5M3.9M386.0K(481.0K)
EBT (Pre-Tax Income)(14.0M)(11.9M)(16.5M)(5.1M)(3.5M)
Income Tax Expense—3.0K10.0K32.0K24.0K
Bottom Line
Net Income(14.0M)(11.9M)(16.4M)(4.9M)(3.2M)
Earnings from Cont. Ops(14.0M)(11.9M)(16.5M)(5.1M)(3.5M)
Earnings from Discont. Ops—————
Bottom Line Net Income(14.0M)(11.9M)(16.4M)(4.9M)(3.2M)
Per Share
Basic EPS($56.54)($89.60)($3,953.62)($6,634.98)$52.37
Diluted EPS($56.54)($89.60)($3,953.62)($6,634.98)$52.37
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding687353132951415874511151
Diluted Shares Outstanding687353132951415874511151
Profitability Metrics
EBITDA(14.1M)(11.9M)(16.5M)(5.0M)(3.3M)
D&A12.0K14.0K25.0K45.0K57.0K
EBIT(14.1M)(11.9M)(16.5M)(5.1M)(3.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026